Public annual accounts

Dr. Julie Dillemans financials

Name: Dr. Julie Dillemans financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Julie Dillemans, with comparable measures and links to available source documents.

Company overview

Registry number

1001170850

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for Dr. Julie Dillemans

2025 versus 2024

Operating line: €216,820
EBITDA: €216,705
Total assets: €471,590
Equity: €233,680

EBITDA margin +99.9% · Equity ratio +49.6%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€216,820	€216,705	€471,590	€233,680	-
202430 Sept 2024	€98,730	€98,730	€107,118	€76,716	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202530 Sept 2025

€216,820

€216,705

€471,590

€233,680

202430 Sept 2024

€98,730

€107,118

€76,716